AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tubitere Novo 80mg Injection

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Docetaxel (80mg)

Overview Tubitere Novo 80mg Injection

NovoTub 80mg Injection is a chemotherapy agent indicated for treating breast, non-small cell lung, prostate, and head and neck cancers. Administration is solely via injection by a healthcare professional. Dosage and frequency are determined by your physician based on your specific condition and may vary. Adhere strictly to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue use only upon your doctor's instruction. Common side effects include shortness of breath, constipation, swelling, infections, appetite loss, myalgia, nail problems, pain, and fatigue. Your doctor may prescribe additional medication to mitigate these effects. Report any unusual bruising or bleeding, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests are crucial to monitor blood cell levels and liver function. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, including antibiotics, to your doctor. Interactions with other drugs are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout the treatment period.

Uses of Tubitere Novo 80mg Injection

Cancers affecting the breast, lung (non-small cell), prostate, and head/neck.

Major Benefits of Tubitere Novo 80mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Tubitere Novo 80mg Injection:

  • Breathlessness
  • Constipation
  • Edema (swelling)
  • Infection
  • Loss of appetite
  • Muscle pain
  • Nail disorder
  • Pain
  • Weakness

How to use Tubitere Novo 80mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

How Tubitere Novo 80mg Injection works:

Novo-Tub 80mg injection is a cancer treatment that disrupts microtubule function, essential for cancer cell division and proliferation. This inhibits cancer cell growth, leading to their demise.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Tubitere Novo 80mg Injection is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Tubitere Novo 80mg Injection during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingUNSAFE

Administration of Tubitere Novo 80mg Injection is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while using Tubitere Novo 80mg Injection is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Renal impairment does not necessitate dosage modification for Tubitere Novo 80mg Injection, which is considered safe for use in such patients.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when administering Tubitere Novo 80mg Injection. Dosage modification of Tubitere Novo 80mg Injection may be necessary. Physician consultation is advised.

What if you forget to take Tubitere Novo 80mg Injection :

NA

Facts to Know About Tubitere Novo 80mg Injection

LabelValue
Type of Compound Taxane-based medications
Addictive None.
Medication Classification Cancer therapeutics
Mechanism of Action Microtubule-disrupting drugs: Taxane class

FAQs on Tubitere Novo 80mg Injection

Weight gain is a possible side effect of Tubitere Novo 80mg Injection. This can result from fluid retention, often manifesting initially as swollen feet before potentially affecting the entire body. Consult your physician promptly if you experience foot swelling.
Continue using Tubitere Novo 80mg Injection under your physician's guidance. Treatment length depends on your cancer type and your response to therapy. Infusions are typically administered every three weeks.
Tubitere Novo 80mg Injection includes alcohol as an ingredient, potentially causing disorientation, unsteady gait, excessive drowsiness, or a sensation akin to intoxication. This effect could compromise your ability to operate vehicles or machinery immediately following administration. Therefore, abstain from alcohol consumption while undergoing Tubitere Novo 80mg Injection treatment to prevent negative consequences.
Novo-Tubitere 80mg injection is frequently administered in the treatment of breast cancer, specific lung cancers, prostate cancer, gastric cancer, and cancers affecting the head and neck. Its mechanism of action involves inhibiting cellular proliferation.
Tubitere Novo 80mg Injection is administered intravenously as a liquid solution by healthcare professionals in a clinical setting. The injection is typically infused over a 60-minute period, with administrations occurring every 21 days.
Prior to each administration of Tubitere Novo 80mg Injection, your physician will require blood work. This may include a complete blood count and liver function tests to verify adequate blood cell levels and liver health for safe injection. Low white blood cell counts can lead to fever or infections.
Alopecia is a frequently reported adverse reaction associated with Tubitere Novo 80mg Injection. Hair regrowth typically occurs following discontinuation of Tubitere Novo 80mg Injection. Nevertheless, irreversible hair loss can occur in certain instances. Seek medical advice if you experience hair loss concerns.
Administration of Tubitere Novo 80mg Injection can lead to edema (swelling in the extremities) and serious allergic responses. Prophylactic corticosteroids (dexamethasone) are provided to all patients for three days, commencing one day before Tubitere Novo 80mg Injection is given, to mitigate these risks. For individuals with metastatic castration-resistant prostate cancer, the prescribed dexamethasone regimen involves oral administration at 12, 3, and 1 hour prior to Tubitere Novo 80mg Injection infusion.
Novo-Tubitere 80mg injection is a taxoid, a class of anticancer drugs. Its mechanism of action involves inhibiting the proliferation and metastasis of malignant cells.
Tubitere Novo 80mg Inject...
8,896
MRP 10,322
13% off